ATAD2 and cancer: Survival analysis showed that several of the dysregulated genes (e.g. ATAD2, BRMS1L, PUF60, SHQ1, and USP4) have an impact on prognosis in multiple cancer types, thereby further highlighting the clinical significance of aberrant gene expression patterns on patient survival.